KS

Karat Sudheer

Active Director Director DIN 08385593
DIN 08385593 First appointment Jul 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Jul 2019
Shareholding value •••• Premium profile

About Karat Sudheer

Data last updated:

Karat Sudheer is a Director at Ingex Lab Private Limited (since 2020), Director at Ingex Botanicals Limited (since 2021) and Director at Ingex Foods Private Limited (since 2021), and holds 1 more current directorship. The companies operate in Healthcare and Food and Beverages. The 4 current companies with reported revenue have a combined latest revenue of ₹221 Cr; the largest is Ingex Lab Private Limited at ₹131 Cr (FY 2025). Earlier, Karat Sudheer was a Whole-Time Director at Olive Lifesciences Private Limited (2019–2020).

DIN 08385593
Primary Designation Director
Industry Healthcare
First Appointment 17 Jul 2019
Oldest Company Age 9 yrs
Largest company Ingex Lab Private Limited · ₹131 Cr (FY 2025)
Combined revenue ₹221 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ingex Lab Private Limited U74994KA2017PTC106540
Director17 Dec 20202017₹131 Cr (FY 2025)Active
Ingex Botanicals Limited U24304KA2020PLC140603
Director01 Sep 20212020₹84.61 Cr (FY 2025)Active
Ingex Foods Private Limited U15490KA2019PTC122132
Director01 Dec 20212019₹4.08 Cr (FY 2025)Active
Nutrinorm Wellness Private Limited U01100KA2017PTC103321
Director08 Apr 20242017₹48 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Olive Lifesciences Private Limited U24230KA2007PTC043892
Whole-Time Director17 Jul 20192007₹16.35 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Karat Sudheer

NameDINCompanyDesignation
Saudmuhamed07867931Ingex Lab Private Limited , Ingex Botanicals Limited and 2 moreWhole-Time Director
Joseph Varkey Molath07717500Ingex Botanicals LimitedDirector

Directorship timeline

Open interactive timeline →
Ingex Foods Private Limited
Ingex Botanicals Limited
Ingex Lab Private Limited
Nutrinorm Wellness Private Limited
Premium access

Shareholding and investment profile for Karat Sudheer

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Karat Sudheer

Karat Sudheer currently holds 4 directorships: Ingex Lab Private Limited (Director, since 17 Dec 2020, revenue ₹131 Cr (FY 2025)); Ingex Botanicals Limited (Director, since 01 Sep 2021, revenue ₹84.61 Cr (FY 2025)); Ingex Foods Private Limited (Director, since 01 Dec 2021, revenue ₹4.08 Cr (FY 2025)); Nutrinorm Wellness Private Limited (Director, since 08 Apr 2024, revenue ₹48 Lakh (FY 2025)).

Karat Sudheer was first appointed on 17 Jul 2019 as Whole-Time Director at Olive Lifesciences Private Limited. The most recent appointment on record is 08 Apr 2024 at Nutrinorm Wellness Private Limited.

The 4 current companies of Karat Sudheer that report revenue have a combined latest revenue of ₹221 Cr: Ingex Lab Private Limited ₹131 Cr (FY 2025); Ingex Botanicals Limited ₹84.61 Cr (FY 2025); Ingex Foods Private Limited ₹4.08 Cr (FY 2025); Nutrinorm Wellness Private Limited ₹48 Lakh (FY 2025).

Karat Sudheer held 1 earlier board appointment: Olive Lifesciences Private Limited (Whole-Time Director, 17 Jul 2019 to 16 Dec 2020).

The current boards of Karat Sudheer's companies include Saudmuhamed (Ingex Lab Private Limited), Joseph Varkey Molath (Ingex Botanicals Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available